Drug Co-Pay Programs During COVID-19

Updated April 27, 2020

Mallinckrodt Statement on Treatment of Infantile Spasms During COVID-19

Updated April 17, 2020

UCB Financial Assistance During COVID-19 Pandemic

For patients, our ucbCARES team is standing by and able to answer questions from patients and stakeholders. We understand many patients and families are facing hardship due to the COVID-19 pandemic and may experience difficulty affording UCB medicines due to job loss, job furlough, or loss of insurance coverage. Staying true to our core beliefs, UCB is committed to ensuring patients, whose physicians have prescribed our medications, have uninterrupted access to their needed treatments. As such, we have expanded our existing Patient Assistance Program (PAP) to help eligible patients who have been impacted by COVID-19 by expediting enrollment to help ensure uninterrupted access to their medicines at no cost. We’re asking patients to contact ucbCARES at (844) 599-CARE (2273) or by email at UCBCares@ucb.com to see if they qualify.

Updated April 3, 2020

Greenwich Biosciences: Epidiolex® Co-Pay Savings Program